These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. New tactics for hyperthyroidism: sympathetic blockade. Joffe BI; Pimstone BL; Riddle MC; Schwartz TB Ann Intern Med; 1970 Dec; 73(6):1044. PubMed ID: 4401852 [No Abstract] [Full Text] [Related]
44. Effect of aptin, a beta-adrenergic blocking agent, in arterial hypertension. Furberg C; Michaelson G Acta Med Scand; 1969 Nov; 186(5):447-50. PubMed ID: 4392230 [No Abstract] [Full Text] [Related]
45. Alprenolol and propranolol in hyperthyroid tachycardia. Turner P Br J Pharmacol; 1970 Sep; 40(1):146P-147P. PubMed ID: 4395079 [No Abstract] [Full Text] [Related]
46. Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias. Phillips EM; Turner P; Houghton J; Ferriman DG Postgrad Med J; 1973 Jan; 49(567):18-23. PubMed ID: 4147246 [TBL] [Abstract][Full Text] [Related]
47. Antihypertensive therapy with alprenolol, a beta-adrenergic receptor antagonist. Tibblin G; Ablad B Acta Med Scand; 1969 Nov; 186(5):451-7. PubMed ID: 4392231 [No Abstract] [Full Text] [Related]
48. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study. Sealey BJ; Liljedal J; Nyberg G; Ablad B Br Heart J; 1971 Jul; 33(4):481-8. PubMed ID: 4397626 [No Abstract] [Full Text] [Related]
49. Ineffectiveness of isoxsuprine on intermittent claudication. Strandness DE JAMA; 1970 Jul; 213(1):86-8. PubMed ID: 4393178 [No Abstract] [Full Text] [Related]
50. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease]. De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269 [No Abstract] [Full Text] [Related]
51. Beta-adrenergic blockade in the treatment of hyperthyroidism. S Afr Med J; 1968 Dec; 42(47):1277. PubMed ID: 5719974 [No Abstract] [Full Text] [Related]
52. PHARMACODYNAMIC EFFECTS OF BETA-ADRENERGIC RECEPTOR BLOCKADE IN PATIENTS WITH HYPERTHYROIDISM. WILSON WR; THEILEN EO; FLETCHER FW J Clin Invest; 1964 Aug; 43(8):1697-703. PubMed ID: 14201553 [No Abstract] [Full Text] [Related]
54. Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man. Kofi Ekue JM; Lowe DC; Shanks RG Br J Pharmacol; 1970 May; 38(3):546-53. PubMed ID: 4392540 [TBL] [Abstract][Full Text] [Related]
55. Sectral in the management of angina pectoris. Lewis BS; Bakst A; Kitchiner DJ; Gotsman MS S Afr Med J; 1973 Aug; 47(32):1455-9. PubMed ID: 4146876 [No Abstract] [Full Text] [Related]
56. Practolol in hyperthyroid cardiac failure. Epstein S; Pimstone B S Afr Med J; 1971 Jul; 45(29):812-4. PubMed ID: 4398485 [No Abstract] [Full Text] [Related]
57. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis]. Vavrejnová V; Felt V; Nedvídková J Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827 [No Abstract] [Full Text] [Related]
58. Relative potency of intravenous prinodolol and propranolol in man. Arbab AG; Hicks DC; Turner P Br J Pharmacol; 1971 Aug; 42(4):665P-666P. PubMed ID: 4940273 [No Abstract] [Full Text] [Related]
59. [The treatment of thyrotoxicosis with beta-blocking agents]. Dogliotti L; Fonzo D; Lauro R; De Martinis C Minerva Med; 1971 Oct; 62(77):3679-84. PubMed ID: 4398567 [No Abstract] [Full Text] [Related]
60. Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation. Dufour R; Scazziga B; Schelling JL Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):145-7. PubMed ID: 4395480 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]